表紙
市場調査レポート

Echo Pharmaceuticals B.V. - 製品パイプライン分析

Echo Pharmaceuticals B.V. - Product Pipeline Review - 2015

発行 Global Markets Direct 商品コード 310066
出版日 ページ情報 英文 23 Pages
即納可能
価格
本日の銀行送金レート: 1USD=101.50円で換算しております。
Back to Top
Echo Pharmaceuticals B.V. - 製品パイプライン分析 Echo Pharmaceuticals B.V. - Product Pipeline Review - 2015
出版日: 2015年10月21日 ページ情報: 英文 23 Pages
概要

Echo Pharmaceuticals B.V. は様々な治療分野で医薬品を開発・製造している製薬会社です。同社製品には浄化技術、製剤技術、 カプセル化技術を用いたカンナビノイドという錠剤があります。また、様々な細胞核から複素環分子を開発しています。

当レポートでは、Echo Pharmaceuticals B.V.における治療薬開発パイプラインの現況と各開発段階の比較分析、薬剤標的、作用機序、投与経路、分子タイプ別の治療薬の評価、最新の企業ニュースや発表、後期段階および中止されたプロジェクトに関する情報などを提供しています。

Echo Pharmaceuticals B.V.の概要

  • 主要情報
  • 企業情報

Echo Pharmaceuticals B.V.:R&Dの概要

  • 主な治療範囲

Echo Pharmaceuticals B.V.:パイプラインのレビュー

  • 開発段階別のパイプライン製品
  • 単剤製品

Echo Pharmaceuticals B.V.:パイプライン製品の概況

  • 治験段階にあるパイプライン製品
    • 第II相にある製品/併用療法モダリティ
    • 第I相にある製品/併用療法モダリティ
  • 初期段階にあるパイプライン製品
    • 創薬中の製品/併用療法モダリティ

Echo Pharmaceuticals B.V.:薬剤プロファイル

  • dronabinol
  • ECP-012A
  • ECP-015

Echo Pharmaceuticals B.V.:パイプライン分析

  • 標的別
  • 投与経路別
  • 分子タイプ別
  • 作用機序別

Echo Pharmaceuticals B.V.:最近のパイプライン動向

Echo Pharmaceuticals B.V.:本社と子会社の所在地

付録

図表一覧

このページに掲載されている内容は最新版と異なる場合があります。詳細はお問い合わせください。

目次
Product Code: GMDHC07691CDB

Summary

Global Markets Direct's, 'Echo Pharmaceuticals B.V. - Product Pipeline Review - 2015', provides an overview of the Echo Pharmaceuticals B.V.'s pharmaceutical research and development focus.

This report provides comprehensive information on the current therapeutic developmental pipeline of Echo Pharmaceuticals B.V.'s, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. It also reviews latest updates, and featured news and press releases, along with special features on late-stage and discontinued projects.

Global Markets Direct's report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from Global Markets Direct's proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by Global Markets Direct's team. Drug profiles/records featured in the report undergoes periodic updation following a stringent set of processes that ensures that all the profiles are updated with the latest set of information. Additionally, processes including live news & deals tracking, browser based alert-box and clinical trials registries tracking ensure that the most recent developments are captured on a real time basis.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage. It strengthens R&D pipelines by identifying new targets and MOAs to produce first-in-class and best-in-class products.

Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

  • The report provides brief overview of Echo Pharmaceuticals B.V. including business description, key information and facts, and its locations and subsidiaries
  • The report reviews current pipeline of Echo Pharmaceuticals B.V.'s human therapeutic division and enlists all their major and minor projects
  • The report features product description and descriptive mechanism of action for key pipeline products along with the product's developmental history and major milestones
  • Special feature on out-licensed and partnered product portfolio
  • The report summarizes all the dormant and discontinued pipeline projects
  • Latest company statement
  • Latest news and deals relating to the Echo Pharmaceuticals B.V.'s pipeline products

Reasons to buy

  • Evaluate Echo Pharmaceuticals B.V.'s strategic position with total access to detailed information on its product pipeline
  • Assess the growth potential of Echo Pharmaceuticals B.V. in its therapy areas of focus
  • Identify new drug targets and therapeutic classes in the Echo Pharmaceuticals B.V.'s R&D portfolio and develop key strategic initiatives to reinforce pipeline in those areas
  • Exploit in-licensing opportunities by identifying windows of opportunity to fill portfolio gaps
  • Develop strategic initiatives by understanding the focus areas of Echo Pharmaceuticals B.V. and exploit collaboration and partnership opportunities
  • Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
  • Plan mergers and acquisitions effectively by identifying the most promising pipeline of Echo Pharmaceuticals B.V.
  • Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope
  • Explore the dormant and discontinued projects of Echo Pharmaceuticals B.V. and identify potential opportunities in those areas
  • Avoid Intellectual Property Rights related issues

Table of Contents

  • Table of Contents
    • List of Tables
    • List of Figures
  • Echo Pharmaceuticals B.V. Snapshot
    • Echo Pharmaceuticals B.V. Overview
    • Key Information
    • Key Facts
  • Echo Pharmaceuticals B.V. - Research and Development Overview
    • Key Therapeutic Areas
  • Echo Pharmaceuticals B.V. - Pipeline Review
    • Pipeline Products by Stage of Development
    • Pipeline Products - Monotherapy
  • Echo Pharmaceuticals B.V. - Pipeline Products Glance
    • Echo Pharmaceuticals B.V. - Clinical Stage Pipeline Products
      • Phase II Products/Combination Treatment Modalities
      • Phase I Products/Combination Treatment Modalities
    • Echo Pharmaceuticals B.V. - Early Stage Pipeline Products
      • Discovery Products/Combination Treatment Modalities
  • Echo Pharmaceuticals B.V. - Drug Profiles
    • dronabinol
      • Product Description
      • Mechanism of Action
      • R&D Progress
    • ECP-012A
      • Product Description
      • Mechanism of Action
      • R&D Progress
    • ECP-015
      • Product Description
      • Mechanism of Action
      • R&D Progress
  • Echo Pharmaceuticals B.V. - Pipeline Analysis
    • Echo Pharmaceuticals B.V. - Pipeline Products by Target
    • Echo Pharmaceuticals B.V. - Pipeline Products by Route of Administration
    • Echo Pharmaceuticals B.V. - Pipeline Products by Molecule Type
    • Echo Pharmaceuticals B.V. - Pipeline Products by Mechanism of Action
  • Echo Pharmaceuticals B.V. - Recent Pipeline Updates
  • Echo Pharmaceuticals B.V. - Locations And Subsidiaries
    • Head Office
    • Other Locations & Subsidiaries
  • Appendix
    • Methodology
    • Coverage
    • Secondary Research
    • Primary Research
    • Expert Panel Validation
    • Contact Us
    • Disclaimer

List of Tables

  • Echo Pharmaceuticals B.V., Key Information
  • Echo Pharmaceuticals B.V., Key Facts
  • Echo Pharmaceuticals B.V. - Pipeline by Indication, 2015
  • Echo Pharmaceuticals B.V. - Pipeline by Stage of Development, 2015
  • Echo Pharmaceuticals B.V. - Monotherapy Products in Pipeline, 2015
  • Echo Pharmaceuticals B.V. - Phase II, 2015
  • Echo Pharmaceuticals B.V. - Phase I, 2015
  • Echo Pharmaceuticals B.V. - Discovery, 2015
  • Echo Pharmaceuticals B.V. - Pipeline by Target, 2015
  • Echo Pharmaceuticals B.V. - Pipeline by Route of Administration, 2015
  • Echo Pharmaceuticals B.V. - Pipeline by Molecule Type, 2015
  • Echo Pharmaceuticals B.V. - Pipeline Products by Mechanism of Action, 2015
  • Echo Pharmaceuticals B.V. - Recent Pipeline Updates, 2015
  • Echo Pharmaceuticals B.V., Other Locations

List of Figures

  • Echo Pharmaceuticals B.V. - Pipeline by Top 10 Indication, 2015
  • Echo Pharmaceuticals B.V. - Pipeline by Stage of Development, 2015
  • Echo Pharmaceuticals B.V. - Monotherapy Products in Pipeline, 2015
  • Echo Pharmaceuticals B.V. - Pipeline by Top 10 Target, 2015
  • Echo Pharmaceuticals B.V. - Pipeline by Top 10 Route of Administration, 2015
  • Echo Pharmaceuticals B.V. - Pipeline by Top 10 Molecule Type, 2015
  • Echo Pharmaceuticals B.V. - Pipeline Products by Top 10 Mechanism of Action, 2015
Back to Top